SBI Securities’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

SBI Securities’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.8K	Sell	909 -106	-10%	-$4.9K	﹤0.01%	1188
2025 Q4	$46.1K	Sell	1,015 -99	-9%	-$4.39K	﹤0.01%	1118
2025 Q3	$43.3K	Sell	1,114 -179	-14%	-$6.48K	﹤0.01%	1144
2025 Q2	$43.6K	Sell	1,293 -34	-3%	-$1.08K	﹤0.01%	1108
2025 Q1	$42.2K	Buy	1,327 +34	+3%	+$1.29K	﹤0.01%	1043
2024 Q4	$50.2K	Buy	+1,293	New	+$54.3K	﹤0.01%	989

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

SBI Securities's GNOM Position: Q1 2026 in Review

SBI Securities reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 10% in Q1 2026, selling an estimated $4.9K and leaving 909 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

SBI Securities first reported a position in GNOM in Q4 2024 and has held it in 6 quarters since. The position peaked at $50.2K in Q4 2024. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

SBI Securities held 909 shares of Global X Genomics & Biotechnology ETF worth $39.8K as of Q1 2026.
SBI Securities sold 106 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $4.9K.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #1188 holding.
SBI Securities first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
SBI Securities's Global X Genomics & Biotechnology ETF position peaked at $50.2K in Q4 2024.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.